Search

Filters
Clear All
  • 13
  • 18
  • 89

Phase

  • 8
  • 4
  • 20
  • 2
  • 23
  • 2
  • 61
  • 119
  • 15

Found 120 will-simon trials

A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

E
Eric Vachon
14 years - 100 years
All genders
We are conducting a study on adults and children with cancer diagnoses to complete a survey about describing cancer survivorship.  This biennial survey study is a part of ongoing efforts Indiana University Simon Comprehensive Cancer Center (IUSCCC) and the Office of Community (COE) to better understand our cancer center’s catchment …
 The Susan G Komen Tissue Bank at the IU Simon Cancer Center A Collection and Storage of Biological Specimens Intended for use in the Elucidation of Breast Carcinogenesis
M
Michele Cote
18 years - 100 years
Accepts healthy volunteer
All genders
Would you like to contribute to the fight against breast cancer?  You can help by donating a breast tissue sample during an event at the IU Melvin and Bren Comprehensive Cancer Center from 8 am to 2 pm on October 19th, 2024.  While the donation process takes only 60-90 minutes, …
H
Huda Salman
18 years - 100 years
All genders
This study investigates the safety and effectiveness of CD4CAR T cell therapy for patients with relapsed or refractory CD4+ chronic myelomonocytic leukemia (CMML). CMML is a type of blood cancer that affects white blood cells, which have a protein called CD4. The CD4CAR T cell therapy is designed to target …
C
Courtney Schroeder
18 years - 100 years
Male
Observational
What is the purpose of this study?Our goals of the study include (1) Evaluating whether we can identify “at-risk” patients with localized prostate cancer who have positive germline mutations not previously known, (2) Identifying which, if any, specific pre-identified “at-risk” population groups are individually at an increased risk of carrying …
M
Mateusz Opyrchal, MD, PhD
18 years or above
All genders
Observational
What is the purpose of this study?The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validatehis process and to predict responses to therapies and use it to choose the …
S
Shelley Johns
18 years - 100 years
All genders
This study investigates a singing intervention for breast cancer survivors who experience stress, anxiety, or depressive symptoms. Breast cancer is a disease where cells in the breast grow out of control. This study aims to find out if singing can provide support and relief to individuals who have survived breast …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 1
This study investigates advanced breast cancer treatment using investigational imaging and therapeutic agents. The purpose of this study is to evaluate the safety and effectiveness of these agents in patients with hormone receptor positive and HER2 negative breast cancer. The imaging agent, designed to detect cancer lesions, will be used …
J
Jennifer Ivanovich
18 years or below
All genders
What is the purpose of this study?In partnership with Indiana Biosciences Research Institute, we will develop new models to study pediatric osteosarcoma. We will invite children with Li-Fraumeni syndrome, hereditary retinoblastoma syndrome, or Rothmund-Thompson syndrome to participate. These three syndromes are associated with an increased risk to develop osteosarcoma. THIS STUDY …
L
Lauren Nephew
18 years - 100 years
All genders
The objective of this study is to pilot test a multi-level intervention designed to address patient- and system-level social and structural determinants of health (SSDOH) variables and facilitate access to curative hepatocellular carcinoma (HCC) therapies, including liver transplantation and resection, in a cohort of Black patients with Barcelona Clinic Liver …
M
Mateusz Opyrchal, MD, PhD
18 years - 100 years
All genders
Phase 1/2
What is the purpose of this study?Phase 1a Dose Escalation/Cohort Expansion BBO-10203 Monotherapy Primary: To evaluate the safety and tolerability of BBO-10203, an inhibitor of the PI3Kα:RAS interaction, in subjects with locally advanced unresectable or metastatic (ie, advanced) HER2-positive BC; HR-positive, HER2-negative BC; KRAS mutant NSCLC; and KRAS mutant CRC. Secondary: To evaluate …
1 - 10 of 120